Download ![]() |
< Back |
01 Jun 2024 | |
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we wish to inform you that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company have approved the appointment of Ms. Shikha Mirchandani Chatrath as Director - Commercial Excellence, BD & Strategy with effect from June 17, 2024, | |
View all announcements for ASTRAZENECA PHARMA INDIA LTD. | Source: BSE India |